Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
about
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease researchComparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to orangesExpanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted ApproachesUnfolded Protein Response and Macroautophagy in Alzheimer's, Parkinson's and Prion DiseasesBlood-Based Proteomic Biomarkers of Alzheimer's Disease PathologyFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsThe Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionAgeing, neurodegeneration and brain rejuvenationNeuroinflammation in Alzheimer's diseaseGenetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkersA Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's DiseaseTracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkersWhite matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNIPhosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid.Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort.Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential.Circulating biomarkers that predict incident dementia.Is Alzheimer's disease a systemic disease?The future of blood-based biomarkers for Alzheimer's disease.A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotypePlasma proteins predict conversion to dementia from prodromal diseaseInfluence of genetic variation on plasma protein levels in older adults using a multi-analyte panel.Circulating miRNA biomarkers for Alzheimer's diseaseAnalysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-studyParallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP/PS1 rat model of Alzheimer's disease.Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease.Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues.The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status.Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele.Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study.Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementiasThe link between C-reactive protein and Alzheimer's disease among Mexican Americans.Biomarkers of Alzheimer's disease among Mexican Americans.Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain.
P2860
Q24289435-3A6B06EA-39EF-4B76-A2DF-0F20FD0D9CD0Q24289443-4BF7E6E5-422B-4287-9C87-9AD3EB8E0014Q26770708-FB079CC1-214C-4916-A46F-2F04EA2833B9Q26773443-49DB438B-B798-4082-A8D0-A350AE8B0093Q26774743-664BB3C4-F22E-42C9-B8A9-0D6DA4C976EFQ26784569-2CDA4AB7-AFE8-4867-BAC0-66CB59D8816AQ27006831-2814794C-BA3C-4767-8492-525D55A143A7Q28071590-3DB6FB97-5F1C-4195-A86F-3895D0390169Q28259238-1E5FF6F3-99D2-4A1D-9EC5-79FA78D96F49Q28542010-A4F936F0-8139-4848-9359-CA82A207A0C2Q28547333-80FBB0CD-A82D-4053-BAEE-519835EF36DFQ29620245-7DFF30D7-8E55-4F6C-98A5-79BD6C927AF1Q30620060-7AF130E8-BD2F-4AC1-AD6C-29C0765D72BBQ30971403-36779E08-3671-4422-B2B3-ECB5578A017FQ31110973-C3978666-895C-40E8-A9BC-C716404E6F62Q33554802-C0C33BEB-3A91-4CE9-817A-0292AFA48E1FQ33637672-19CC715A-1B55-4C31-954C-0DA05BFDEB3AQ33652456-0B8E47B7-31F9-4DCB-80C1-9A3796F11D65Q33692408-922B7620-9D13-4D69-B062-4BE38FF2B170Q33752058-A6FCB900-1389-4D94-AE3E-404FB4FC5F9FQ34019193-5115832C-F4A2-4C9C-A6A1-DAE2B853AE74Q34026317-354D58B0-B016-4594-86D6-F9C8F79B2CB4Q34363475-339C7D70-5921-4C12-B202-72F99CF0C40BQ34556953-C501D05B-D10E-443C-ABDC-A18793ECDBFAQ34875967-2050A3E3-367C-4A95-856E-DE8E13A4025AQ34904013-F2195B0E-8B34-4CE0-9833-37E1DCC225F0Q35034827-89B827BF-8541-4D19-9D24-1B5AC402D4DBQ35071220-D3AF8804-8059-4398-A5F4-6A51C89422C8Q35099780-1671DDEB-22C3-4A53-8DD5-69C895A0B787Q35456060-4AC36714-9926-4E6F-8A56-B357E87BF1CEQ35502548-AF7B0FBF-0244-4FB1-B1C0-9B75872011C7Q35804607-EC88E417-FBAD-4BFF-8290-FC4887CE8064Q35990600-5546B635-0E2D-4621-81B3-4B3FCE434D6FQ36032418-378F6A4A-A45F-45A4-A377-AEACA2D8E0D3Q36033650-DF00A8D8-E0F3-490C-B1C5-1CDFE420B289Q36353787-4DAE1184-CAE5-45D5-B6FF-17902D7991EAQ36595660-6CEB25BD-E167-458D-8B42-710DA06674E5Q36716958-786ACFE6-F437-458E-8E00-8A8F5542333DQ36716970-8160F61B-6BC1-44F3-8460-2EA208F57715Q36836566-C185DBC7-87E2-4AAA-80A8-9558D5BF2EDB
P2860
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
@ast
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
@en
type
label
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
@ast
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
@en
prefLabel
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
@ast
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
@en
P2093
P2860
P50
P1433
P1476
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
@en
P2093
Alice Chen-Plotkin
Chengjie Xiong
Christopher M Clark
Eve Pickering
Frank Swenson
Holly Soares
Howard I Hurtig
Lauren Elman
Leo McCluskey
Leslie M Shaw
P2860
P304
P356
10.1212/WNL.0B013E318266FA70
P407
P50
P577
2012-08-01T00:00:00Z